Legislation Filed to Allow In State
"Manufacture" of Medical Cannabis
House Bill 722, titled "Health; patient registry program for the use of medical cannabis", has been filed by Representatives Allen Peake, Alan Powell and Micah Gravely. Peake has been a familiar face in the news dating back to last year's session where he championed "Haleigh's Hope Act". Last year's bill, signed into law by Governor Nathan Deal, allows for the usage of cannabis oil to treat a limited number of medical conditions. Peake recently made news again when he resigned as Governor Deal's floor leader in the house citing a difference of opinion with the governor with respect to expanding Georgia's medical cannabis laws.
Peake's latest legislation would allow for the "manufacture" of medical cannabis in Georgia by no less than two, and no more than six, licensed producers to be chosen byDecember 1, 2016. These manufactures would be required to begin distributing the cannabis to patients by July 1, 2017. The system is modeled on similar rules in place in Minnesota. The producers must operate four distribution facilities located around the state to improve patient access. Aside from meeting an extensive list of requirements, applicants to manufacture medical cannabis will be assessed a $20,000 application fee.
At its November 2015 meeting, the GGIA Board of Directors decided that the association will neither support nor oppose the legalization of cannabis production or any expansion of the current laws related to medical cannabis. The board does recognize the fact that in state production will be of interest to some members and has decided that we will closely monitor and report on any legislative activity on the subject. This bill will undoubtedly receive a great amount of media attention as the session gets underway. Indications suggest that there is split support for the expansion as one would expect. GGIA has communicated our position to Representative Peake and will engage if we see that legislation has the possibility of impacting the industry. We fully realize that this is a sensitive and complex issue and plan to give careful consideration before we act in any way with respect to this pending legislation. As always, we welcome your comments. Contact GGIA Executive Director, Chris Butts, at email@example.com or directly at 706-540-2813.
You may click here for a copy of the proposed legislation.